Published in TB and Outbreaks Week, March 20th, 2001
M.L. Bernardini and colleagues set out to find the strain of Shigella that was likely to offer the most protection, and to define parameters such as ideal route of administration and whether disease protection corresponded to antibody response in plasma. Their results were published in Infection and Immunity.
The researchers inoculated guinea pigs intranasally with three strains of Shigella flexneri: ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.